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Background: In most sub-Saharan African countries malaria rapid diagnostic tests (RDTs) are now used for the
diagnosis of malaria. Most RDTs used detect Plasmodium falciparum histidine-rich protein-2 (PfHRP2), though
P. falciparum-specific parasite lactate dehydrogenase (Pf-pLDH)-detecting RDTs may have advantages over
PfHRP2-detecting RDTs. Only few data are available on the use of RDTs in severe illness and the present study
compared Pf-pLDH to PfHRP2-detection.
Methods: Hospitalized children aged one month to 14 years presenting with fever or severe illness were
included over one year. Venous blood samples were drawn for malaria diagnosis (microscopy and RDT),
culture and complete blood count. Leftovers were stored at −80 °C and used for additional RDT analysis and
PCR. An RDT targeting both PfHRP2 and Pf-pLDH was performed on all samples for direct comparison of
diagnostic accuracy with microscopy as reference method. PCR was performed to explore false-positive RDT
results.
Results: In 376 of 694 (54.2%) included children, malaria was microscopically confirmed. Sensitivity, specificity,
positive predictive value (PPV) and negative predictive value were 100.0, 70.9, 69.4 and 100.0%, respectively
for PfHRP2-detection and 98.7, 94.0, 91.6 and 99.1%, respectively for Pf-pLDH-detection. Specificity and PPV
were significantly lower for PfHRP2-detection (p <0.001). For both detection antigens, specificity was lowest
for children one to five years and in the rainy season. PPV for both antigens was highest in the rainy season,
because of higher malaria prevalence. False positive PfHRP2 results were associated with prior anti-malarial
treatment and positive PCR results (98/114 (86.0%) samples tested).
Conclusion: Among children presenting with severe febrile illness in a seasonal hyperendemic malaria
transmission area, the present study observed similar sensitivity but lower specificity and PPV of PfHRP2
compared to Pf-pLDH-detection. Further studies should assess the diagnostic accuracy and safety of an appropriate
Pf-pLDH-detecting RDT in field settings and if satisfying, replacement of PfHRP2 by Pf-pLDH-detecting RDTs
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Malaria rapid diagnostic tests (RDTs) are currently rolled
out in sub-Saharan Africa to fulfill the need of parasite
based diagnosis e.g. the parasitological confirmation of
malaria before start of treatment [1]. The operational
characteristics of RDTs have been extensively evaluated
for uncomplicated malaria [2] and the parasite-based diag-
nosis strategy has proven to be safe in uncomplicated mal-
aria [3]. In contrast, only a few studies addressed the use
of RDTs in children presenting with severe illness. Those
performed reported low specificity of Plasmodium falcip-
arum histidine-rich protein-2 (PfHRP2)-detecting RDTs
[4,5], which is most probably due to PfHRP2 persistence
after clearance of infection [6]. An alternative would be an
RDT detecting P. falciparum-specific parasite lactate de-
hydrogenase (Pf-pLDH), which is more rapidly cleared
from the bloodstream, but lower sensitivities compared to
PfHRP2 have been reported [4]. However recent evalua-
tions of other Pf-pLDH-detecting RDT products have
shown better performance, also at low parasite densities
[7-9]. The RDT used by the national malaria control
programme of Burkina Faso detects PfHRP2, which is rec-
ommended by the World Health Organization (WHO)
[10] and used in most sub-Saharan African countries. The
current diagnostic algorithm in Burkina Faso recommends
treatment of malaria in case of a positive test and search
for other causes of disease when negative [11], but does
not differentiate between severe and non-severe disease.
The aim of this study was to compare Pf-pLDH to
PfHRP2-detecting RDTs in children presenting with se-
vere febrile illness in a seasonal, hyperendemic, malaria
transmission area.
Methods
Study site and population
A one-year survey (July 2012–2013) to assess propor-
tions and incidence rates of invasive bacterial infections
and severe malaria was performed in a rural area in the
centre-west region of Burkina Faso. In this region there
is seasonal hyperendemic malaria transmission and the
estimated under-five mortality in 2010 was 142/1,000
live births [12]. Details of the study have been published
elsewhere [13]. In summary, children (<15 years) pre-
senting with axillary temperature ≥38.0 °C and/or clin-
ical signs of severe illness who were admitted to the
hospital or health centre were enrolled. Signs of severe
illness included convulsions, altered consciousness, pros-
tration, respiratory distress, shock, hypothermia and se-
vere malnutrition. For the present study, children < one
month of age were not considered.
Sample collection
In all children enrolled blood culture was performed and
ethylene diamine tetra-acetic acid (EDTA)-anticoagulatedvenous blood samples were drawn for malaria diagnosis
(both microscopy and RDT). Laboratory analysis was per-
formed in the clinical research unit of Nanoro (CRUN),
located on the compound of the district hospital. Leftovers
of EDTA blood samples were stored at 80 °C within a
maximum of two hours after sampling until further ana-
lysis. Medical history, including previous anti-malarial
treatment, and clinical examination were registered on
standardized forms by trained study staff.Laboratory procedures
Thick blood films (TBF) were stained with Giemsa and
assessed for the presence of Plasmodium parasites ac-
cording to standard procedures [14]. Parasite density
was expressed as asexual parasites per μl using the pa-
tient’s white blood cell (WBC) count. TBF was consid-
ered negative if no parasites were seen on 100 fields.
Every slide was read by two experienced microscopists
blinded to each other’s results and in case of discrepant
results (positive vs negative, different Plasmodium spe-
cies, difference in parasite density > Log10 or ratio >2 in
case of parasite density ≤400/μl and >400/μl, respect-
ively) by a third experienced microscopist.
The RDT SD Bioline Malaria Antigen P.f (Standard
Diagnostics, Hagal-Dong, Korea), further referred to as
SD50 (LOT 082160), is the RDT recommended by the na-
tional malaria control programme of Burkina Faso and de-
tects the protein PfHRP2. SD50 was performed on EDTA
blood samples by trained CRUN laboratory staff before
slides were read and within a maximum of two hours after
sampling. Blood culture work-up and cerebrospinal fluid
analysis was performed according to standard microbio-
logical procedures as described previously [13].Malaria rapid diagnostic test evaluated
The RDT SD Bioline Malaria Antigen P.f (HRP2/pLDH)
(Standard Diagnostics, Hagal-Dong, Korea), further re-
ferred to as SD90 (LOT RDT12002), is a three-band test
consisting of a control line and two test lines targeting
PfHRP2 and Pf-pLDH, respectively. Good performance
was reported in previous evaluations [15,16]. SD90 was
performed on EDTA blood samples according to the
manufacturer’s instructions except for replacement of
the transfer device by a micropipette. From February to
July (n = 276), SD90 was performed on fresh samples
side-to-side to SD50 by CRUN laboratory staff. For the
remaining samples (n = 420) SD90 was performed on
stored samples at the end of the study period by the
investigator.
In case of absence of the control line the test was con-
sidered invalid and repeated. Test line intensities were
scored as negative, faint, weak, medium, or strong com-
pared to the control line by a single observer who was
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tographs were taken.
Monitoring and quality control
A selection of slides (5%) was sent to the Institute of Trop-
ical Medicine (ITM) and again read by an expert micro-
scopist whose results were considered conclusive. SD50
and SD90 were ordered at ITM Belgium and shipped to
Burkina Faso where they were stored in a temperature-
controlled room. The actual kit in use was stored in the
parasitology laboratory. Temperature and humidity during
shipment and storage were monitored using loggers (Ebro
Electronic GmBH, Ingolstadt, Germany).
For discordant results between either SD50 or SD90
and microscopy, samples were retrieved from −80 °C
storage and both RDTs were repeated by the investigator
blinded to microscopy results. The result of the repeat
testing was considered for analysis in case the first result
was performed by CRUN staff. If both the first and re-
peat testing was performed by the investigator, the first
result was considered. Photographs taken were verified
to exclude clerical errors.
In order to compare PfHRP2 results of SD50 and
SD90, the RDTs were performed side to side on 10%
randomly selected stored samples. For SD50, these 10%
of stored samples were also compared to results ob-
tained when prospectively performed on fresh samples.
Additional analysis: polymerase chain reaction (PCR)
Real-time polymerase chain reaction (PCR) was performed
in case of discordant results between microscopy and
RDT. DNA was extracted from 200 ml whole blood using
QIAamp DNA blood Mini kit (QIAGEN, Venlo, The
Netherlands) or from TBF if needed [17]. DNA was
amplified by a species-specific 18S rRNA real-time
PCR (P. falciparum/Plasmodium vivax [18]), the Plas-
modium ovale/Plasmodium malariae duplex was run
simultaneously to confirm microscopically identified
non-falciparum species.
Data management, definitions and analysis
Data were double-entered in Epi info software (version
3.5.3). Statistical analysis was done with Stata 11 (Stata
Corp, College Station, TX, USA). For the purpose of
this study, microscopy was considered as the gold
standard. Samples with asexual P. falciparum parasites
seen on TBF (irrespective of parasite density and either
as mono-infection or as mixed infection with P. ovale
or P. malariae) were categorized as P. falciparum posi-
tive. The remaining samples, including samples with pure
P. falciparum gametocytaemia, P. ovale or P. malariae as
well as those with no parasites seen, were categorized as
P. falciparum negative. For SD90, sensitivity and specifi-
city were calculated for both PfHRP2 and Pf-pLDH testlines. A visible test line in case of P. falciparum positive
samples was considered true positive, no visible test line
false negative. For P. falciparum negative samples, the ab-
sence of a visible test line was labelled as true negative, a
visible line was labelled as false positive. Sensitivity, speci-
ficity and predictive values were calculated by age group
and season and expressed with 95% CI. Differences were
assessed for statistical significance using the Chi-square
test, or Fisher exact test when appropriate, in case of inde-
pendent data (e.g., comparison between the seasons) and
with the McNemar test or paired proportion test for
dependent data (PfHRP2 vs Pf-pLDH).
Ethical issues
The study was approved by the ethical committee of
Burkina Faso and the University Hospital of Antwerp
and by the institutional review board of ITM. Written
informed consent was obtained from the parent or
guardian of each child included.
Results
Study population and malaria microscopy results
During the one-year study period, 696 children aged one
month to 14 years were included [13]. For two children
(both P. falciparum positive with parasite densities of
62/μl and 35,194/μl, respectively), there was evidence of
a sample switch during storage, both samples were ex-
cluded from analysis. The final collection consisted of
694 samples.
Demographic data of participants during the different
seasons are shown in Table 1. Seasons were divided into
rainy season (July to October, monthly microscopy posi-
tivity rate 67.9-87.9%), post-rainy season (November to
February, monthly microscopy positivity rate 31.4-40.0%)
and hot dry season (March to June, monthly microscopy
positivity rate 2.9-17.2%).
In 376 (54.0%) children, samples were P. falciparum
positive, five of them had a mixed infection with P. malar-
iae (n = 3) and P. ovale (n = 2). Median P. falciparum
parasite density was 43,231.5/μl (25–702,500). Among
the P. falciparum negative samples (318/694, 45.8%),
two had P. ovale infection and 13 had pure P. falcip-
arum gametocytaemia.
Diagnostic accuracy of PfHRP2 and Pf-pLDH
No invalid results were observed for SD90. PfHRP2 and
Pf-pLDH positivity rates are shown in Figure 1. Among
the P. falciparum-positive samples, PfHRP2 was positive
in all samples while Pf-pLDH missed one (parasite dens-
ity 62/μl, Table 2), resulting in an overall sensitivity of
100 and 99.5% for PfHRP2 and Pf-pLDH, respectively (p =
1.0). Among the P. falciparum-negative samples, there
were 139 and 29 false-positive PfHRP2 and Pf-pLDH lines,
respectively (Figure 2), corresponding to specificities of
Table 1 Demographic profile and diagnosis of children included during the different seasons
All year Rainy season Post-rainy season Dry season
Number 694 398 151 145
Age, median months (IQR) 20 (11–37) 21 (12–37) 16 (9–35) 17 (9–39)
Female sex, n (%) 310 (44.7) 176 (44.2) 79 (52.3) 55 (37.9)
Prior antimalarial treatment, n (%) 302 (43.5) 156 (39.2) 87 (57.6) 59 (40.7)
Microscopy Pf positive 376 (54.2) 304 (76.4) 55 (36.4) 17 (11.7)
Pf parasite density/μl, median 42,331 49,962.5 18,256 7,549
Pf parasite density/μl, range 25 - 702,500 62 - 702,500 99 - 259,685 25 - 112,465
Blood culture positive, n (%) 60 (8.7%) 19 (4.8) 27 (17.9) 14 (9.7)
Confirmed meningitis, n (%) 6 (0.9) 1 (0.3) 2 (1.3) 3 (2.1)
Co-infections 7 (1.0) 4 (1.0) 3 (2.0) 0
IQR = interquartile range, n = number, Pf = P. falciparum.
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ciparum-negative samples both test lines were visible: they
included eight samples with pure gametocytaemia. PfHRP2
was positive in an additional 114 samples, including an-
other four samples with pure gametocytaemia. False posi-
tive Pf-pLDH test lines in the absence of PfHRP2 lines
occurred in four samples of which two were P. ovale infec-
tion and one pure gametocytaemia.
Overall, positive predictive value (PPV) for PfHRP2-
detection (73.0%) was significantly lower compared to
Pf-pLDH detection (92.8%, p <0.001) while negative pre-
dictive values (NPV) were similar (Table 3).
PfHRP2 and Pf-pLDH performance by age group
PfHRP2 specificity was significantly lower among chil-
dren aged one to five years (39.6%) compared to chil-
dren < one year (70.9%) or > five years (68.4%, p <0.001Figure 1 Microscopy, PfHRP2 and Pf-pLDH positivity rate by month
Pf-pLDH = positivity rate of Pf-pLDH.for both), for Pf-pLDH differences among age groups
were not significant (p = 0.053 and p = 0.134, respect-
ively, Table 4). As the slide-positivity rate was highest
among children one to five years of age, PPV for PfHRP2
in this age group did not differ significantly from the
others despite lower specificity (p = 0.428 and p = 0.255).
PfHRP2 and Pf-pLDH seasonal performance
Sensitivity of PfHRP2 and Pf-pLDH detection did not
differ throughout the year (Table 4). PfHRP2 specificity
was significantly higher in the hot dry season (78.9%)
compared to the rainy and post-rainy season (35.1 and
46.9%, respectively, both p <0.001). As slide positivity-
rate was highest in the rainy season, PPV of PfHRP2 was
highest in the rainy season (83.3%), despite lowest speci-
ficity, and decreased to 51.9 and 38.6% in the other two
seasons. Specificity of Pf-pLDH detection was in all. Micro = microscopy positivity rate, PfHRP2 = positivity rate of PfHRP2,
Table 2 PfHRP2 and Pf-pLDH results according to parasite
density









1 - 100 3 2 1
101 - 1,000 25 25
1,001 - 10,000 66 66
10,001 - 100,000 199 199
> 100,000 83 83
pure gametocytemia 13 8 4 1
Microscopy negative 303 17 110 1 175
P. ovale 2 2
Total 694 400 115 4 175
Neg=negative, pos = positive, PfHRP2 = P. falciparum Histidine-rich protein-2,
Pf-pLDH = P. falciparum-specific parasite lactate dehydrogenase.
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for each season). Also for Pf-pLDH-detection PPV was
highest in the rainy season, although differences were
smaller: 95.6% in the rainy season compared to 82.1%
(p <0.001) and 85.0% (p = 0.071) in the post-rainy and
hot dry season, respectively.
RDT positivity among children with invasive bacterial
infections
Microscopy was positive in eight out of 64 (12.5%) chil-
dren with invasive bacterial infections (IBI), PfHRP2 and
Pf-pLDH were positive in 33/64 (51.6%) and 12/64
(18.8%), respectively. As described previously [13] non-Figure 2 False positive rapid diagnostic test results per month compa
among all children included per month, FP PfHRP2 = % false positive PfHRP2 r
Pf-pLDH results among total positive Pf-pLDH results.typhoid Salmonella spp. (NTS) were most frequently
isolated from blood culture (21/60, 35.0%). PfHRP2 was
positive among 17/21 (81.0%) NTS, which was signifi-
cantly more frequent compared to Pf-pLDH (6/21, 28.6%,
p = 0.002) and microscopy (2/21, 9.5%, p < 0.001).
RDT line intensity
For Pf-pLDH, 2.4% (nine/375) of true positive test lines
was of faint intensity, for PfHRP2 this was 0.5% (two/
376). For the P. falciparum positive samples, the PfHRP2
test line compared to the corresponding Pf-pLDH test
line for the same sample was of stronger and weaker in-
tensity in 179/376 (47.6%) and 31/376 (8.2%) samples,
respectively. For seven samples with high parasite dens-
ity (82,080-392,535/μl) PfHRP2 was of weak intensity
while Pf-pLDH was of strong intensity. Among the false
positive test lines (excluding pure gametocytaemia), two/
20 (10%) Pf-pLDH and 67/126 (53.2%) PfHRP2 lines
were of medium or strong intensity.
RDT results of retesting and quality control
During the side-to-side comparison of PfHRP2 of SD50
and SD90, no discordances between positive and nega-
tive results were observed and differences in line inten-
sity were limited to one category. When comparing
results of SD50 performed on fresh and stored samples,
no differences in positive/negative results nor major dif-
ferences in line intensities (more than one category)
were observed, except for one originally strong result
which was faint on repeat testing but for which clerical
error could not be excluded.red to microscopy positivity rate. Micro = microscopy positivity rate
esults among total positive PfHRP2 results, FP PfpLDH = % false positive
Table 3 Diagnostic accuracy of PfHRP2- compared to
Pf-pLDH-detection
PfHRP2 Pf-pLDH p-value
RDT pos, n (%) 515 (74.2) 404 (54.2)
SE (95% CI) 100.0 (94.7 - 100.0) 98.7 (93.5-99.9) 1.0
Sp (95% CI) 70.9 (67.4 - 70.9) 94.0 (90.6 - 94.8) < 0.001
PPV (95% CI) 69.4 (65.7 - 69.4) 91.6 (86.8 - 92.7) < 0.001
NPV (95% CI) 100.0 (95.1 - 100.0) 99.1 (95.5 - 100.0) 1.0
N = number, NPV = negative predictive value, PfHRP2 = P. falciparum Histidine-rich
protein-2, Pf-pLDH = P. falciparum-specific parasite lactate dehydrogenase
pos = positive, PPV = positive, predictive value SE = sensitivity, Sp = specificity.
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In 139/318 P. falciparum-negative samples the PfHRP2
line was visible, including 12 samples with pure gameto-
cytaemia. For the latter, ten/12 were obtained in children
reporting previous anti-malarial treatment and eight/12
had a visible Pf-pLDH line. Figure 3 summarizes the
results of PCR, Pf-pLDH and previous anti-malarial
treatment for the false positive PfHRP2 results (exclud-
ing pure gametocytaemia) for which PCR was per-
formed (n = 114): Pf-pLDH was positive in 16 (14.0%)
samples, PCR in 98 (86.0%) and previous anti-malarial
treatment was reported in 75 (65.8%). For five samples,
none of the aforementioned items was positive.
Among both PfHRP2 and Pf-pLDH false positive re-
sults, report of previous anti-malarial treatment was sig-
nificantly higher (66.2 and 86.2%, respectively) compared
to microscopy positive samples (33.3%, p <0.001 for





(95% C.I.) (95% C.I.) (95% C.I.)
Age (m)
1 – 11 194 39.7 100.0 70.9 69.4
94.7-100.0 67.4-70.9 65.7-69.4
12 – 59 401 64.1 100.0 39.6 74.7
98.3-100.0 36.6-39.6 73.5-74.7
≥ 60 99 42.4 100.0 68.4 70.0
91.1-100.0 61.9-68.4 63.8-70.0
Season
Rainy 398 76.4 100.0 35.1 83.3
98.7-100.0 30.8-35.1 82.2-83.3
Post-rainy 151 36.4 100.0 46.9 51.9
92.7-100.0 42.7-46.9 48.1-51.9
Hot dry 145 11.7 100.0 78.9 38.6
78.7-100.0 76.1-78.9 30.4-38.6
Pf = P. falciparum, PfHRP2 = P. falciparum Histidine-rich protein-2, Pf-pLDH = P. falcip
Sp = specificity, PPV = positive predictive value, NPV = negative predictive value.Discussion
The present study assessed the diagnostic accuracy of
PfHRP2 compared to Pf-pLDH antigen detection in chil-
dren presenting with severe febrile illness in a rural area
with seasonal malaria transmission. Both antigens had
excellent sensitivity and similar negative predictive values,
but PfHRP2 had a lower specificity resulting in a signifi-
cantly lower positive predictive value. Specificity was low-
est in the rainy season, but due to the high malaria
prevalence PPV was highest in the rainy season. The ma-
jority of false-positive PfHRP2 lines were PCR positive
and/or reported recent anti-malarial treatment, part
of them were also Pf-pLDH positive or had pure
gametocytaemia.
Limitations
A number of limitations need to be considered. First, al-
though the present study allowed reliable comparison
between Pf-pLDH and PfHRP2-detection, which was the
study objective, the RDT evaluated is not a format that
is likely to be used in field settings. However, the simul-
taneous side-to-side testing of SD90 and SD50 showed
similar results, therefore data about PfHRP2 perform-
ance can probably be extrapolated to the actual situation
in Burkina Faso. Second, RDTs were performed and
interpreted by an experienced investigator using a cali-
brated pipette, which may have generated higher sensi-
tivities than would have been obtained under field
conditions. Furthermore, 60% of SD90 was performed
on stored samples, although samples had been stored forgroup and by season
Pf-pLDH
NPV SE Sp PPV NPV
(95% C.I.) (95% C.I.) (95% C.I.) (95% C.I.) (95% C.I.)
100.0 98.7 94.0 91.6 99.1
95.1-100.0 93.5-99.9 90.6-94.8 86.8-92.7 95.5-100.0
100.0 100.0 86.8 93.1 100.0
92.5-100.0 98.4-100.0 84.0-86.8 91.6-93.1 96.7-100.0
100.0 100.0 94.7 93.3 100.0
90.4-100.0 92.3-100.0 89.1-94.7 86.2-93.3 94.0-100.0
100.0 99.7 85.1 95.6 98.8
87.6-100.0 98.2-100.0 80.5-86.1 94.2-95.9 93.4-99.9
100.0 100.0 87.5 82.1 100.0
91.1-100.0 93.2-100.0 83.6-87.5 76.5-82.1 95.5-100.0
100.0 100.0 97.7 85.0 100.0
96.4-100.0 81.7-100.0 95.2-97.7 69.5-85.0 97.5-100.0
arum-specific parasite lactate dehydrogenase, pos = positive, SE = sensitivity,
Figure 3 Positive polymerase chain reaction and Pf-pLDH
results and report of previous anti-malarial treatment for
false-positive PfHRP2 samples. Only those samples with false
positive PfHRP2 for which PCR was performed are displayed (n = 114).
AM Tx = previous anti-malarial treatment, PfpLDH = positive Pf-pLDH
test line, PCR = positive PCR result. For five children none of the
aforementioned was positive.
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to testing; in addition, repeat testing on a subset of sam-
ples showed no difference in results when performed on
fresh or stored samples.
Sensitivity
So far, only two studies have evaluated the diagnostic ac-
curacy of RDTs in children suspected of severe malaria,
one in Mozambique and Tanzania [4] and another in
Tanzania [5]. The former compared a Pf-pLDH with a
PfHRP2-detecting RDT: they observed a significant lower
sensitivity for the Pf-pLDH-detecting RDT (88.0 vs
94.0%), especially at low (<1,000/μl) parasite densities.
Of note however, the test used (Optimal-IT) is a multi-
step RDT with reported lower sensitivities compared
to more recent one-step Pf-pLDH-detecting RDT prod-
ucts [8,19]. In the present study there was excellent sensi-
tivity of Pf-pLDH detection, also at low parasite densities.
Only one sample was missed by Pf-pLDH detection and
this sample had a parasite density of 62/μl, which is below
the detection threshold of routine microscopy [20].
Faint test lines, which are prone to be disregarded by
health workers [21-23], only occurred in 0.5 and 2.4% of
the true positive PfHRP2 and Pf-pLDH lines, respect-
ively. The co-presence of weak PfHRP2 and strong Pf-
pLDH lines at high parasite densities (n = 7), may be
caused by the prozone effect (false negative/low test
lines due to an antigen excess [24]), but was presently
not further assessed. Only PfHRP2-detecting RDTs are
affected by the prozone effect, not Pf-pLDH [24,25]. Thedegree to which RDTs are affected by prozone is product
dependent and in some products PfHRP2 lines may be
completely absent [24], leading to false negative results.
The weak line intensities at high parasite densities are
also of concern, as they may be considered as non-
severe disease [23,26].
Specificity
When interpreting specificity, several factors should be
addressed: first, although in the present study slides were
double-read by experienced microscopists, very low
parasite densities may have been missed. Next, exclusive
presence of gametocytes was considered as P. falciparum
negative (as they do not cause clinical infection) but they
produce PfHRP2 and Pf-pLDH [27,28] explaining the
apparent false positive results. For the purpose of this
study PCR was not considered as reference method, be-
cause it may detect submicroscopic infections (reflecting
asymptomatic carriage) which do not explain clinical
symptoms [29]. The false positive Pf-pLDH lines ob-
served in the present study can in part be explained by a
(ongoing and partly) treated malaria infection from the
previous days as Pf-pLDH becomes negative in a me-
dian of two to seven days after start of effective treat-
ment [30,31]. This was presently supported by its
association with a history of recent anti-malarial treat-
ment. In addition, there were three false positive Pf-pLDH
results for which both PfHRP2 and PCR were nega-
tive. Possible explanations may be cross-reaction with
pLDH produced by P. ovale (n = 2) or other interfer-
ing factors [32].
The interpretation of false positive PfHRP2 lines is
more complex. The most common cause of false positive
PfHRP2 results, especially in high-transmission areas, is
PfHRP2 persistence. Other possibilities, though rare, are
non-specific bindings or interference with other im-
munological or infectious factors, such as the rheuma-
toid factor, hepatitis C, schistosomiasis, toxoplasmosis,
dengue, leishmaniasis, Chagas disease and human Afri-
can trypanosomiasis [19,33-36].
For the PCR negative samples, it can assumed that the
false positive PfHRP2 lines were due to past infection,
approximately two to six weeks ago. For the PCR posi-
tive samples, the subsequent question arises whether the
children were actually suffering from malaria at the time
of sampling and had negative microscopy because of re-
cently (<two days) started anti-malarial treatment (on-
going infection) [37] or whether it was a recently cleared
infection with the child now suffering from another dis-
ease. Indeed, microscopy turns negative within one to
two days after start of artemisinin-based combination
therapy (ACT) [38], but the time of PCR to become
negative after start of treatment has not yet been stud-
ied, although one study reported that upon completion
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still positive by real time PCR [39]. As the proportion of
positive PCR results among false positive PfHRP2 sam-
ples was high in the present study, it can be assumed
that at least part of the false-positive PfHRP2 lines can
be explained by ongoing and partly treated infection, es-
pecially in those samples that showed false positive Pf-
pLDH results as well.
Prior use of anti-malarial treatment (either by self-
medication or prescription) reflects real-life situation in
malaria-endemic settings. To know if the child is actu-
ally suffering from malaria, an ideal RDT should be able
to differentiate ongoing infection from a previously cur-
rently cured episode of infection, but PfHRP2 is not cap-
able of doing so. Pf-pLDH RDTs seem to be more
promising in that respect as they turn negative in two to
seven days, but future studies should assess their evolu-
tion over time after start of treatment.
Influence of age and season on specificity
The low PfHRP2 specificity in the rainy and post-rainy
season compared to the dry season has been observed
before [40] and may be explained by malaria infection in
the weeks prior to enrolment, as malaria transmission is
high in these months. In addition, children may have had
an actual infection and been (partly) treated before enrol-
ment, which also explains the decreased Pf-pLDH specifi-
city in the rainy and post-rainy season. For children aged
one to five years, specificity for PfHRP2-detection was ex-
tremely low which may be ascribed to their high vulnerabil-
ity to malaria, which was reflected by the high prevalence
in this age group. The relationship has been observed
before [5] while no such association was observed for
Pf-pLDH detection, probably due to the more rapid
clearance from the blood stream [41-43].
What if treatment is based on RDT results?
In children with severe malaria it is crucial that the diag-
nosis is not missed: a negative RDT should safely ex-
clude malaria. However, over diagnosis of malaria by
diagnostic testing not only leads to a waste of anti-
malarial drugs but also increases the risk of ignorance of
other possible life-threatening diseases, such as invasive
bacterial infections, which is especially true for PfHRP2-
detecting RDTs. Even though WHO mentions to look
for other causes of severe illness (including IBI) in the
case of a positive RDT, this strategy is not yet clearly im-
plemented in the diagnostic algorithm of Burkina Faso
[11] and may be overlooked in daily reality, especially
since tools for diagnosis of other diseases are lacking.
Pf-pLDH versus PfHRP2-detecting RDTs
The present data adds to the debate about Pf-pLDH vs
PfHRP2-detecting RDTs. The previously reported lowersensitivity and lower heat stability of Pf-pLDH-detecting
RDTs appeared to be product dependent [19]. Unlike
PfHRP2, Pf-pLDH-detection is not affected by the pro-
zone effect [24], no gene deletions [15] or antigen poly-
morphisms [44-47] have been reported and it is rapidly
cleared from the blood stream [41,42]. Especially be-
cause of its higher specificity, Pf-pLDH-detecting RDTs
may be more useful in malaria-endemic areas. In
addition it may be that Pf-pLDH-detecting RDTs are
more cost-beneficial compared to presumptive diagno-
sis in high-transmission settings, which was not the
case for PfHRP2-detecting RDTs as concluded by
Bisoffi et al. [48]. This needs however to be further
evaluated.Future perspectives
To what extent can the present study findings be ap-
plied? First, an appropriate Pf-pLDH-detecting RDT
should be selected and assessed for its diagnostic accur-
acy and robustness in field studies. Currently only few
Pf-pLDH-detecting RDT products are available on the
international market [32], and only one three-band RDT
targeting Pf-pLDH and pan-pLDH and one two-band
RDT targeting pan-pLDH fulfilled WHO criteria of good
performance [49]. More emphasis should be on develop-
ment and optimization of Pf-pLDH-detecting RDTs, and
it should be evaluated how fast they become negative
during anti-malarial treatment. If future field evaluations
of Pf-pLDH-detecting RDTs are satisfying, the recom-
mendation of WHO to use PfHRP2-detecting RDTs in
P. falciparum-endemic areas in sub-Saharan Africa [10]
should be reconsidered. In the meantime, diagnostic al-
gorithms should better highlight the possibility of inva-
sive bacterial infections in spite of a positive RDT result.Conclusion
Among children presenting with severe febrile illness in
a region with seasonal hyperendemic malaria transmis-
sion, similar sensitivity but lower specificity of PfHRP2
compared to Pf-pLDH-detection was observed. Specifi-
city of PfHRP2 was lowest in the rainy season but PPV
was highest in this season due to the high malaria preva-
lence. For each season and age group, the PPV of PfHRP2
was lower compared to Pf-pLDH. Part of the apparent
false-positive PfHRP2 samples might however be due to
parasite clearance after (incomplete or ongoing) treatment
with anti-malarials at home or at the referring health
centre. Further studies should assess the diagnostic accur-
acy and safety of an appropriate Pf-pLDH-detecting RDT
in field settings and its capacity to distinguish ongoing
malaria from recently cleared infections. If satisfying,
replacement of PfHRP2-detecting RDTs by Pf-pLDH-
detecting RDTs should be considered.
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